Related Experiment Video
Updated: Mar 1, 2026
08:15
Generation of a RIP1 Knockout U937 Cell Line Using the CRISPR-Cas9 System
Published on: April 11, 2025
963
Generation of SMURF2 knockout human cells using the CRISPR/Cas9 system
Dhanoop Manikoth Ayyathan1, Nataša Ilić1, Hava Gil-Henn2
1Laboratory of Molecular and Cellular Cancer Biology, Faculty of Medicine in the Galilee, Bar-Ilan University, Safed, Israel.
Analytical Biochemistry
|May 30, 2017
Summary
Researchers developed methods to create cancer cell models lacking SMURF2, a protein linked to tumor growth. These models are crucial for understanding SMURF2's role in cancer development and progression.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- SMURF2 (HECT domain E3 ubiquitin ligase) influences protein targets critical for cell processes like proliferation and migration.
- Altered SMURF2 levels are observed in various cancers, but its precise role in tumorigenesis remains unclear.
Purpose of the Study:
- To investigate the function of SMURF2 in cancer.
- To establish human normal and cancer cell models with SMURF2 knocked out.
Main Methods:
- Utilized CRISPR/Cas9 gene-editing technology.
- Generated human normal and cancer cell strains lacking SMURF2.
Main Results:
- Successfully created human cell models with SMURF2 gene knockout.
- These models provide a platform for studying SMURF2's function in cancer.
Conclusions:
- The developed CRISPR/Cas9-based approach enables the generation of essential cellular tools for cancer research.
- These SMURF2-knockout models will aid in elucidating SMURF2's involvement in tumorigenesis.
